SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-206106
Filing Date
2005-10-24
Accepted
2005-10-21 18:27:07
Documents
3
Period of Report
2005-10-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 US ONCOLOGY HOLDINGS, INC. FORM 8-K d8k.htm 8-K 14271
2 PRESS RELEASE dex991.htm EX-99.1 9155
3 GRAPHIC g58445image002.jpg GRAPHIC 4016
  Complete submission text file 0001193125-05-206106.txt   30694
Mailing Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060
Business Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060 (832) 601-8766
US Oncology Holdings, Inc. (Filer) CIK: 0001333191 (see all company filings)

IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-126922 | Film No.: 051150675
SIC: 8060 Services-Hospitals